MF59 Adjuvant
- Generic Name
- MF59 Adjuvant
Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza
- Conditions
- Avian InfluenzaInfluenza Immunisation
- Interventions
- First Posted Date
- 2018-09-24
- Last Posted Date
- 2021-05-17
- Target Recruit Count
- 372
- Registration Number
- NCT03682120
- Locations
- 🇺🇸
Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States
🇺🇸Kaiser Permanente Washington Health Research Institute - Vaccines and Infectious Diseases, Seattle, Washington, United States
🇺🇸University of Alabama at Birmingham School of Medicine - Alabama Vaccine Research Clinic, Birmingham, Alabama, United States
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology
- Conditions
- Avian Influenza
- Interventions
- First Posted Date
- 2017-01-09
- Last Posted Date
- 2024-07-05
- Target Recruit Count
- 388
- Registration Number
- NCT03014310
- Locations
- 🇺🇸
Duke Vaccine and Trials Unit, Durham, North Carolina, United States
🇺🇸The University of Texas Medical Branch - Sealy Center for Vaccine Development (SCVD), Galveston, Texas, United States
🇺🇸Emory University School of Medicine, Atlanta, Georgia, United States
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
- Conditions
- Avian InfluenzaInfluenza
- Interventions
- First Posted Date
- 2015-12-08
- Last Posted Date
- 2019-10-23
- Target Recruit Count
- 276
- Registration Number
- NCT02624219
- Locations
- 🇺🇸
University of Iowa - Vaccine Research and Education Unit, Iowa City, Iowa, United States
🇺🇸Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States
🇺🇸Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States
A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
- Conditions
- Avian InfluenzaImmunisation
- Interventions
- Biological: Influenza Virus Vaccine, Live Attenuated H7N9 Anhui 2013/AA caBiological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013
- First Posted Date
- 2014-09-29
- Last Posted Date
- 2020-01-27
- Target Recruit Count
- 62
- Registration Number
- NCT02251288
- Locations
- 🇺🇸
University of Rochester Medical Center - Vaccine Research Unit, Rochester, New York, United States
H7N9 Mix and Match With MF59 in Healthy Elderly Persons
- Conditions
- Avian Influenza
- Interventions
- Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013
- First Posted Date
- 2014-08-11
- Last Posted Date
- 2017-07-06
- Target Recruit Count
- 479
- Registration Number
- NCT02213354
- Locations
- 🇺🇸
University of Iowa - Vaccine Research and Education Unit, Iowa City, Iowa, United States
🇺🇸Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States
🇺🇸Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States
H7N9 Mix and Match With AS03 and MF59 in Healthy Adults
- Conditions
- Influenza
- Interventions
- First Posted Date
- 2013-09-13
- Last Posted Date
- 2017-07-06
- Target Recruit Count
- 980
- Registration Number
- NCT01942265
- Locations
- 🇺🇸
Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States
🇺🇸University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States
🇺🇸Vanderbilt University Medical Center - Infectious Diseases, Nashville, Tennessee, United States
H7N9 Mix and Match With MF59 in Healthy Adults
- Conditions
- Influenza
- Interventions
- Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013
- First Posted Date
- 2013-09-10
- Last Posted Date
- 2016-12-12
- Target Recruit Count
- 700
- Registration Number
- NCT01938742
- Locations
- 🇺🇸
Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States
🇺🇸Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States
🇺🇸University of Texas Medical Branch - Pediatrics - Infectious Diseases and Immunology - Galveston, Galveston, Texas, United States
H5N1 Mix and Match With MF59
- Conditions
- Influenza
- Interventions
- First Posted Date
- 2011-03-17
- Last Posted Date
- 2013-01-25
- Target Recruit Count
- 270
- Registration Number
- NCT01317745
- Locations
- 🇺🇸
University of Iowa - Infectious Disease Clinic, Iowa City, Iowa, United States
🇺🇸Emory Children's Center - Division of Pediatric Infectious Diseases, Atlanta, Georgia, United States
🇺🇸Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States
Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults
- Conditions
- Influenza
- Interventions
- Biological: Influenza A/H9N2 vaccine
- First Posted Date
- 2005-08-23
- Last Posted Date
- 2010-08-27
- Target Recruit Count
- 96
- Registration Number
- NCT00133471
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Recombinant CMV gB Vaccine in Postpartum Women
- Conditions
- Cytomegalovirus Infections
- Interventions
- First Posted Date
- 2005-08-01
- Last Posted Date
- 2011-09-20
- Lead Sponsor
- Robert Pass, MD
- Target Recruit Count
- 464
- Registration Number
- NCT00125502
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸University of Alabama at Tuscaloosa, Tuscaloosa, Alabama, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.